2023
Authors: van Weelden G, Dewandel I, de Jonge MI, Redfern A, Bekker C, Lochan H, van der Gaast C, Van Niekerk M, Mentor M, Mfazwe A, Fröberg J, Diavatopoulos D, Donà D, Rabie H, van der Zalm M, Verhagen LM.
Presented at: International Congress of Immunology (IUIS)
2023
Authors: Di Chiara C, Barbieri E, Chen YX, Visonà E, Cavagnis S, Sturniolo G, Parca A, Liberati C, Cantarutti L, Lupattelli A, Le Prevost M, Corrao G, Giaquinto C, Donà D, Cantarutti A.
Published in: Acta Paediatrica
2023
Authors: Donà D, Minotti C, Masini T, Penazzato M, Van Der Zalm MM, Judd A, Giaquinto C, Lallemant M & Survey Respondents Consortium.
Published in: European Journal of Pediatrics
2023
Authors: Ruel T, Penazzato M, Zech JM, Archary M, Cressey TR, Goga A, Harwell J, Landovitz RJ, Lain MG, Lallemant M, Namusoke-Magongo E, Mukui I, Permar SR, Prendergast AJ, Shapiro R, Abrams EJ.
Published in: Global Health: Science & Practice
2023
Authors:
, , , , , , .Published in: MedRxiv (preprint) and Eurosurveillance
2023
ORCHESTRA opens doors to COVID-19 related data to selected scientists
Verona 17/07/2023 – ORCHESTRA-Cohort is a multinational cohort research project on COVID-19 and its long-term sequelae. The collaborative data collection of SARS-CoV-2 infections including long-term follow-ups aims at creating a precise clinical picture of the disease to contribute to better patient care. External scientists are now welcome to apply to participate in a science challenge carried out with patient data of the EU funded project.
2023
Authors: Menegale F, Manica M, Zardini A, Guzzetta G, Marziano V, D’Andrea V, Trentini F, Ajelli M, Poletti P, Merler S.
Published in: JAMA Network Open
2023
Authors: Redfern A, van der Zalm MM, Lishman J, Goussard P, Smit L, Dagan R, Barday M, Mare M, Claassen M, Van Zyl G, Rabie H, Verhagen LM.
Published in: The Pediatric Infectious Disease Journal
2023
Authors: Van der Zalm MM, Donà D, Rabie H.
Published in: Current Opinions in Pediatrics
2023
Authors: Sabatino J, Di Chiara C, Di Candia A, Sirico D, Donà D, Fumanelli J, Basso A, Pogacnik P, Cuppini E, Romano LR, Castaldi B, Reffo E, Cerutti A, Biffanti R, Cozzani S, Giaquinto C, Di Salvo G.
Published in: Journal of Clinical Medicine
2023
Authors: Minotti C, Mengato D, De Pieri M, Trivellato S, Francavilla A, Di Chiara C, Liberati C, Mattera R, Biffi A, Giaquinto C, Venturini F, Donà D.
Published in: Viruses
2023
Authors: De Meijere G, Valdano E, Castellano C, Debin M, Kengne-Kuetche C, Turbelin C, Noël H, Weitz J, Paolotti D, Hermans L, Hens N, Colizza V.
Published in: The Lancet Regional Health – Europe
2022
Authors: Westerhof I, de Hoog M, Ieven M, Lammens C, van Beek J, Rozhnova G, Eggink D, Euser S, Wildenbeest J, Duijts L, van Houten M, Goossens H, Giaquinto C, Bruijning-Verhagen P.
Published in: International Journal of Infectious Diseases
2022
Authors: Donà D, Montagnani C, Di Chiara C, Venturini E, Galli L, Lo Vecchio A, Denina M, Olivini N, Bruzzese E, Campana A, Giacchero R, Salvini F, Meini A, Ponzoni M, Trapani S, Rossi E, Lombardi MH, Badolato R, Pierri L, Pruccoli G, Rossin S, Colomba C, Cazzato S, Pacati I, Nicolini G, Pierantoni L, Bianchini S, Krzysztofiak A, Garazzino S, Giaquinto C, Castelli Gattinara G
Published in: Viruses
2022
A large study on the effectiveness of the Pfizer-BioNTech’s Covid-19 vaccine in children aged 5-11 was published in The New England Journal of Medicine.
The study was conducted at Israel’s largest healthcare organization, Clalit Health Services, in collaboration with researchers from the University of Padua, Harvard University and University College London.
This is one of the first large observational studies that uses Real-World Data evaluate the effectiveness of the Pfizer-BioNTech BNT162b2 (Comirnaty) vaccine in children aged 5-11 against the Omicron variant.
2022
Authors: Cohen-Stavi CJ, Magen O, Barda N, Yaron S, Peretz A, Netzer D, Giaquinto C, Judd A, Leibovici L, Hernán MA, Lipsitch M, Reis BY, Balicer RD, Dagan N.
Published in: The New England Journal of Medicine
2022
Padua, 30 June 2022 – A large study on the effectiveness of the Pfizer Covid-19 vaccine in children aged 5-11 was published in The New England Journal of Medicine.
The study was conducted at Israel’s largest healthcare organization, Clalit Health Services, in collaboration with researchers from the University of Padua, Harvard University and University College London.